Minimally Invasive Treatment Of Lung Cancer Global Market Report 2025

Description

Minimally invasive lung cancer treatment uses small incisions and advanced techniques, such as video-assisted or robotic surgery, to target or remove lung tumors while minimizing damage to surrounding tissues. This method aims to accelerate recovery, reduce complications, and improve patient outcomes compared to conventional open surgery.

The primary types of minimally invasive lung cancer treatments are lung tumor ablation and lung tumor embolization. Lung tumor ablation destroys cancer cells by applying extreme heat or cold directly to the tumor using imaging-guided probes. These treatments are applicable across various stages of lung cancer, including stages I, II, III, and IV, and cover different age groups, such as under 30 years, 31-45 years, and 46-60 years. They are utilized by a range of end users, including hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The minimally invasive treatment for lung cancer market research report is one of a series of new reports from The Business Research Company that provides minimally invasive treatment for lung cancer market statistics, including minimally invasive treatment for lung cancer industry global market size, regional shares, competitors with the minimally invasive treatment for lung cancer market share, minimally invasive treatment for lung cancer market segments, market trends, and opportunities, and any further data you may need to thrive in the minimally invasive treatment for lung cancer industry. This minimally invasive treatment for lung cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The minimally invasive treatment of lung cancer market size has grown strongly in recent years. It will grow from $3.06 billion in 2024 to $3.35 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period can be attributed to the rising prevalence of lung cancer, increasing awareness of minimally invasive procedures, an expanding geriatric population, greater adoption of early diagnostic methods, and the ongoing development of healthcare infrastructure.

The minimally invasive treatment of lung cancer market size is expected to see strong growth in the next few years. It will grow to $4.78 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to the increasing demand for outpatient procedures, growing investment in specialized lung cancer centers, expanded availability of minimally invasive treatment options, government initiatives supporting advanced healthcare, and a focus on minimizing postoperative complications. Key trends in this period include advancements in surgical instrument technology, innovations in patient monitoring systems, development of precision therapy techniques, research in less invasive interventions, and the integration of artificial intelligence for treatment planning.

The rising prevalence of lung cancer is expected to drive the growth of the minimally invasive treatment of lung cancer market in the coming years. Lung cancer, a disease characterized by uncontrolled cell growth in the lungs, is increasingly common due to higher rates of tobacco smoking, which elevate the risk of tumor formation. Minimally invasive treatments benefit lung cancer patients by removing or destroying tumors through small incisions or imaging-guided probes, reducing recovery time, minimizing damage to healthy lung tissue, lowering complication risks, and enabling patients to resume normal activities sooner. For example, in June 2025, the U.S. Centers for Disease Control and Prevention reported 218,893 new lung cancer cases in 2022, resulting in 131,584 deaths. Consequently, the growing incidence of lung cancer is fueling the minimally invasive treatment market.

Companies in the minimally invasive lung cancer treatment market are focusing on advanced technologies, such as fluoroscopic navigation platforms, to enhance precision and enable targeted therapy. These platforms combine real-time fluoroscopy with navigation technology to guide instruments accurately to targeted lung areas, allowing minimally invasive biopsy and treatment of difficult-to-reach lesions while reducing complications. For instance, in July 2022, Medtronic plc, an Ireland-based medical technology company, performed the first endoluminal lung ablation using the ILLUMISITE platform in Hong Kong. This procedure utilized a customized virtual pathway based on the patient's CT scan to guide the bronchoscope to the lung lesion, where a specialized ablation catheter delivered targeted therapy, marking a significant advancement in precise, localized lung cancer treatment.

In February 2025, Toulouse University Hospital in France acquired Epione from Quantum Surgical for an undisclosed amount. This acquisition aims to strengthen the hospital's capacity for minimally invasive, robot-assisted treatment of abdominal and lung tumors, enabling physicians to perform highly precise procedures, improve patient outcomes, reduce recovery times, and expand access to advanced oncological care in the Occitanie region. Quantum Surgical, a France-based medical technology company, specializes in minimally invasive solutions for small and hard-to-reach lung tumors.

Major players in the minimally invasive treatment of lung cancer market are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Weill Cornell Medicine, Accuray Incorporated, Richard Wolf GmbH, AngioDynamics Inc., CMR Surgical Ltd., Biodesix Inc., Guangzhou Geyi Medical Instrument Co. Ltd., Quantum Surgical SA, Scanlan International Inc., RZ Medizintechnik GmbH & Co. KG, August Reuchlen GmbH, SBH Surgical GmbH & Co. KG, Geister Medizintechnik GmbH.

North America was the largest region in the minimally invasive treatment of lung cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in minimally invasive treatment of lung cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the minimally invasive treatment of lung cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The minimally invasive treatment of lung cancer market consists of revenues earned by entities by providing services such as diagnostic imaging, bronchoscopic procedures, chemotherapy delivery, targeted therapy administration and postoperative care. The market value includes the value of related goods sold by the service provider or included within the service offering. The minimally invasive treatment of lung cancer market also includes of sales of implants, catheters, endoscopes, navigation systems and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Minimally Invasive Treatment Of Lung Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on minimally invasive treatment of lung cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for minimally invasive treatment of lung cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The minimally invasive treatment of lung cancer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Lung Tumor Ablation; Lung Tumor Embolization
2) By Stage: Stage I; Stage II; Stage III; Stage IV
3) By Age Group: Under 30 Years; 31 To 45 Years; 46 To 60 Years
4) By End-User: Hospitals; Ambulatory Surgical Centers (ASCs); Specialty Clinics; Research Institutions
Subsegments:
1) By Lung Tumor Ablation: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Laser Ablation
2) By Lung Tumor Embolization: Bronchial Artery Embolization; Pulmonary Artery Embolization; Chemoembolization; Radioembolization
Companies Mentioned: Johnson & Johnson; Medtronic plc; Siemens Healthineers AG; Stryker Corporation; Boston Scientific Corporation; Olympus Corporation; Intuitive Surgical Inc.; Weill Cornell Medicine; Accuray Incorporated; Richard Wolf GmbH; AngioDynamics Inc.; CMR Surgical Ltd.; Biodesix Inc.; Guangzhou Geyi Medical Instrument Co. Ltd.; Quantum Surgical SA; Scanlan International Inc.; RZ Medizintechnik GmbH & Co. KG; August Reuchlen GmbH; SBH Surgical GmbH & Co. KG; Geister Medizintechnik GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37820

1. Executive Summary

2. Minimally Invasive Treatment Of Lung Cancer Market Characteristics

3. Minimally Invasive Treatment Of Lung Cancer Market Trends And Strategies

4. Minimally Invasive Treatment Of Lung Cancer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Minimally Invasive Treatment Of Lung Cancer Growth Analysis And Strategic Analysis Framework

5.1. Global Minimally Invasive Treatment Of Lung Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Minimally Invasive Treatment Of Lung Cancer Market Growth Rate Analysis
5.4. Global Minimally Invasive Treatment Of Lung Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Minimally Invasive Treatment Of Lung Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Minimally Invasive Treatment Of Lung Cancer Total Addressable Market (TAM)

6. Minimally Invasive Treatment Of Lung Cancer Market Segmentation

6.1. Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lung Tumor Ablation
Lung Tumor Embolization
6.2. Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stage I
Stage II
Stage III
Stage IV
6.3. Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Under 30 Years
31 To 45 Years
46 To 60 Years
6.4. Global Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers (ASCs)
Specialty Clinics
Research Institutions
6.5. Global Minimally Invasive Treatment Of Lung Cancer Market, Sub-Segmentation Of Lung Tumor Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Laser Ablation
6.6. Global Minimally Invasive Treatment Of Lung Cancer Market, Sub-Segmentation Of Lung Tumor Embolization, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bronchial Artery Embolization
Pulmonary Artery Embolization
Chemoembolization
Radioembolization

7. Minimally Invasive Treatment Of Lung Cancer Market Regional And Country Analysis

7.1. Global Minimally Invasive Treatment Of Lung Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Minimally Invasive Treatment Of Lung Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Minimally Invasive Treatment Of Lung Cancer Market

8.1. Asia-Pacific Minimally Invasive Treatment Of Lung Cancer Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Minimally Invasive Treatment Of Lung Cancer Market

9.1. China Minimally Invasive Treatment Of Lung Cancer Market Overview
9.2. China Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Minimally Invasive Treatment Of Lung Cancer Market

10.1. India Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Minimally Invasive Treatment Of Lung Cancer Market

11.1. Japan Minimally Invasive Treatment Of Lung Cancer Market Overview
11.2. Japan Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Minimally Invasive Treatment Of Lung Cancer Market

12.1. Australia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Minimally Invasive Treatment Of Lung Cancer Market

13.1. Indonesia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Minimally Invasive Treatment Of Lung Cancer Market

14.1. South Korea Minimally Invasive Treatment Of Lung Cancer Market Overview
14.2. South Korea Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Minimally Invasive Treatment Of Lung Cancer Market

15.1. Western Europe Minimally Invasive Treatment Of Lung Cancer Market Overview
15.2. Western Europe Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Minimally Invasive Treatment Of Lung Cancer Market

16.1. UK Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Minimally Invasive Treatment Of Lung Cancer Market

17.1. Germany Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Minimally Invasive Treatment Of Lung Cancer Market

18.1. France Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Minimally Invasive Treatment Of Lung Cancer Market

19.1. Italy Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Minimally Invasive Treatment Of Lung Cancer Market

20.1. Spain Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Minimally Invasive Treatment Of Lung Cancer Market

21.1. Eastern Europe Minimally Invasive Treatment Of Lung Cancer Market Overview
21.2. Eastern Europe Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Minimally Invasive Treatment Of Lung Cancer Market

22.1. Russia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Minimally Invasive Treatment Of Lung Cancer Market

23.1. North America Minimally Invasive Treatment Of Lung Cancer Market Overview
23.2. North America Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Minimally Invasive Treatment Of Lung Cancer Market

24.1. USA Minimally Invasive Treatment Of Lung Cancer Market Overview
24.2. USA Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Minimally Invasive Treatment Of Lung Cancer Market

25.1. Canada Minimally Invasive Treatment Of Lung Cancer Market Overview
25.2. Canada Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Minimally Invasive Treatment Of Lung Cancer Market

26.1. South America Minimally Invasive Treatment Of Lung Cancer Market Overview
26.2. South America Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Minimally Invasive Treatment Of Lung Cancer Market

27.1. Brazil Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Minimally Invasive Treatment Of Lung Cancer Market

28.1. Middle East Minimally Invasive Treatment Of Lung Cancer Market Overview
28.2. Middle East Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Minimally Invasive Treatment Of Lung Cancer Market

29.1. Africa Minimally Invasive Treatment Of Lung Cancer Market Overview
29.2. Africa Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Minimally Invasive Treatment Of Lung Cancer Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Minimally Invasive Treatment Of Lung Cancer Market Competitive Landscape And Company Profiles

30.1. Minimally Invasive Treatment Of Lung Cancer Market Competitive Landscape
30.2. Minimally Invasive Treatment Of Lung Cancer Market Company Profiles
- 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Minimally Invasive Treatment Of Lung Cancer Market Other Major And Innovative Companies

31.1. Olympus Corporation
31.2. Intuitive Surgical Inc.
31.3. Weill Cornell Medicine
31.4. Accuray Incorporated
31.5. Richard Wolf GmbH
31.6. AngioDynamics Inc.
31.7. CMR Surgical Ltd.
31.8. Biodesix Inc.
31.9. Guangzhou Geyi Medical Instrument Co. Ltd.
31.10. Quantum Surgical SA
31.11. Scanlan International Inc.
31.12. RZ Medizintechnik GmbH & Co. KG
31.13. August Reuchlen GmbH
31.14. SBH Surgical GmbH & Co. KG
31.15. Geister Medizintechnik GmbH

32. Global Minimally Invasive Treatment Of Lung Cancer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Minimally Invasive Treatment Of Lung Cancer Market

34. Recent Developments In The Minimally Invasive Treatment Of Lung Cancer Market

35. Minimally Invasive Treatment Of Lung Cancer Market High Potential Countries, Segments and Strategies

35.1 Minimally Invasive Treatment Of Lung Cancer Market In 2029 - Countries Offering Most New Opportunities
35.2 Minimally Invasive Treatment Of Lung Cancer Market In 2029 - Segments Offering Most New Opportunities
35.3 Minimally Invasive Treatment Of Lung Cancer Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer